Latest News

Nektar Therapeutics (NASDAQ:NKTR) presented new clinical and biomarker findings for rezpegaldesleukin, or REZPEG, at the EADV 2026 Congress, highlighting six-month off-treatment results in severe to very severe alopecia areata and molecular findings from its Phase IIb atopic dermatitis program. REZ

The company faces a delicate balancing act in terms of raising prices and managing volumes in the face of rising costs.

The recent momentum could last much longer.

Delaying CPP until 70 produces a much larger payment, but retirees give up five full years of income.

The AI data center build-out has many years to run, and these stocks are ideally placed to benefit.

Palantir, ServiceNow and AMD each suffered sharp selloffs before rebuilding uptrends, and analyst Marc Chaikin says these reset AI names may offer more upside than stocks already at new highs.

Constellation Energy may offer investors slightly more upside potential in the coming years.

Many earnings reports are due out in October that could shift market sentiment.

State Street's XLP charges just 0.08% annually versus iShares' 0.37%, but IYK diversifies into healthcare and materials. Similar returns and low volatility make this a cost-versus-breadth trade-off.

Here's what S&P 500 history shows.

Regeneron Pharmaceuticals (NASDAQ:REGN) and Sanofi said they are expanding their long-running collaboration to develop and commercialize next-generation medicines for type 2 inflammatory diseases, adding four Regeneron-originated antibody programs and establishing a new equal-sharing economic framew

Micron's fiscal Q4 revenue surged 379% on HBM and NAND demand, with margins and cash flow expanding sharply as analysts raise price targets and capacity stays booked through 2027.

Technology stocks have led the market higher in 2026, fueled by the artificial intelligence boom.

There are three overlooked aspects to the early innings of Stellantis' global turnaround, but here's why the stock could race ahead in the near term.

What Happened? Shares of intelligent lighting and space solutions provider Acuity Brands (NYSE:AYI) fell 5.3% in the morning session after the company announ...

What Happened? Shares of technology and consulting giant IBM (NYSE:IBM) jumped 5.7% in the morning session after the company announced a self-hosted deployme...

What Happened? Shares of enterprise workflow automation company ServiceNow (NYSE:NOW) jumped 3.9% in the morning session after the company launched Flow by S...

What Happened? Shares of digital banking platform Nubank (NYSE:NU) jumped 2.7% in the morning session after the company stated in a regulatory filing that it...

What Happened? Shares of global professional services company Accenture (NYSE:ACN) jumped 23.9% in the morning session after the company delivered third-quar...

What Happened? Shares of american restaurant chain BJ’s Restaurants (NASDAQ:BJRI) jumped 4.4% in the morning session after Mizuho analyst Nick Setyan upgrade...

Investors reacted positively to earnings, but is Accenture stock now too expensive to buy?

Both stocks have increased their dividend by more than 40% in the last five years.

The fourth quarter could see some big momentum shifts for these tech players.

These three high-yield dividend stocks offer income and different risk profiles across pipelines, banking, and Canadian real estate.

It's not always a financially sound choice.